Ventilation-perfusion inequality in asymptomatic asthma. 1978

P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West

Ventilation-perfusion (Va/Q) inequality was measured by a multiple inert gas elimination method in 6 asymptomatic patients with asthma and in a seventh patient during a severe asthmatic episode. Measurements were made before and at 5-min intervals after administration of aerosolized isoproterenol. All patients had some residual airway obstruction as measured during forced expirations. All except one patient had clearly bimodal distributions of Va/Q ratios during all phases of the study, as confirmed by an extensive exploration of distributions compatible with each set of inert gas data. One mode lay within the normal range of Va/Q, but the other, containing 19.8 per cent of the cardiac output on the average, was centered on a Va/Q ratio of only 0.07. There was essentially no shunt. Five min after the administration of isoproterenol, the blood flow to the low Va/Q mode approximately doubled, accounting for the observed decrease in arterial PO2. Breathing 100 per cent O2 had little effect on the distribution. The presence of a bimodal distribution of Va/Q ratios without shunt suggests that collateral ventilation may be an important mechanism determining the distribution of Va/Q ratios and preventing the development of shunts. This study also showed that in some asymptomatic asthmatic patients, as many as one half of the lung units may lie behind completely closed airways and have very low but finite Va/Q ratios as a result of collateral ventilation.

UI MeSH Term Description Entries
D006985 Hyperventilation A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide. Hyperventilations
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D004980 Ethane A two carbon alkane with the formula H3C-CH3.
D004986 Ether A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes. Diethyl Ether,Ether, Ethyl,Ethyl Ether,Ether, Diethyl
D005260 Female Females
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000096 Acetone A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis.

Related Publications

P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
September 1987, The American review of respiratory disease,
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
January 1967, British journal of diseases of the chest,
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
March 1982, The American review of respiratory disease,
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
March 1987, Journal of applied physiology (Bethesda, Md. : 1985),
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
May 1987, Chest,
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
August 2021, Journal of applied physiology (Bethesda, Md. : 1985),
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
May 1988, The American review of respiratory disease,
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
March 1995, Equine veterinary journal,
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
March 1994, Anesthesiology,
P D Wagner, and D R Dantzker, and V E Iacovoni, and W C Tomlin, and J B West
February 1979, Journal of applied physiology: respiratory, environmental and exercise physiology,
Copied contents to your clipboard!